Arsenio L, Bodria P, Magnati G, et al. Effectiveness of long-term treatment with pantethine in patients with dyslipidemia. Clin Ther 1986;8(5):537-45.
Canner PL et al., Fifteen-Year Mortality in Coronary Drug Project Patients: Long-Term Beneflt with Niacin, J Am Coll Cardiol 1986; 8:1245-55.
Carlson LA, Hamsten A, and Asplund A. Pronounced Lowering of Serum Levels of Lipoprotein Lp(a) in Hyperlipidaemic Subjects Treated with Nicotinic Acid. J Intern Med 1989; 226:271-6.
Committee of Principal Investigators, 'World Health Organization Clofibrate Trial: A Co-Operative Trial in the Primary Prevention of Ischemic Heart Disease Using Clofibrate," Br Heart J 1978;40:1069-1118.
Coronel F et al., "Treatment of Hyperlipidemia in Diabetic Patients on Dialysis with a Physiological Substance," Am J Nephrol 1991; 11(1):32-6.
DiPalma JR and Thayer WS. Use of Niacin as a Drug. Ann Rev Nutr. 1991; 11: 169-87.
Donati C, Bertieri RS, and Barbi G, Pantethine, Diabetes Mellitus, and Atherosclerosis: Clinical Study of 1045 Patients, Clin Ter 1989; 128(6): 411-22.
El-Enein AMA et al., "The Role of Nicotinic Acid and Inositol Hexaniacinate as Anticholesterolemic and Antilipemic Agents," Nutr Rep Intl 28 (1983): 899-911.
Ernst E, Cardiovascular Effects of Garlic (Allium sativum): A Review," Pharmatherapeutica 1987; 5: 83-9.
Gaddi A, et al., Controlled Evaluation of Pantethine, a Natural Hypolipidemic Compound, in Patients with Different Forms of Hyperlipoproteinemia, Atheroscl 1984; 50:73-83.
Hallfrisch J et al., "High Plasma Vitamin C Associated with High Plasma HDL- and HDL2 Cholesterol," A J Clin Nutr 60(1994): 100-5.
Hiramatsu K, Nozaki H, and Arimori S, Influence of Pantethine on Platelet Volume, Microviscosity, Lipid Composition, and Functions in Diabetes Mellitus with Hyperlipidemia, Tokai J Exp Clin Med 1981; 6(1): 49-57.
Harris JL, Hibbeln J, Mackey RH, Muldoon MF. Statin treatment alters serum n-3 and n-6 fatty acids in hypercholesterolemic patients. Prostaglandins Leukot Essent Fatty Acids. 2004;71:263–269.
Howard PA and Meyers DG, Effect of Vitamin C on Plasma Lipids Pharmacother 1995; 29: 1129-36.
Illingworth DR et al., "Comparative Effects of Lovastatin and Niacin in Primary Hypercholesterolemia," Arch Intern Med 154 (1994):1586-95.
Jacques PF et al., Ascorbic Acid and Plasma Lipids, Epidemiol 1994;5: 19-26.
Jain AK et al., Can Garlic Reduce Levels of Serum Lipids? A Controlled Clinical Study. Am J Med 1993; 94: 632-5.
Kendler BS, Carlic (Allium sativum)and Onion (Allium cepa): A Review of Their Relationship to Cardiovascular Disease," Prev Med 1987; 16: 670-85.
Kleijnen J et al., Garlic, Onions, and Cardiovascular Risk Factors: A Review of the Evidence from Human Experiments vith Emphasis on Commercially Available Preparations. Br J Clin Pharmacol 1989; 28: 535-44.
Kock H and Lawson L, eds., Carlic: The Science and Therapeutic Application of Allium Sativum L and Related Species, 2nd ed. (Baltimore, MD: Williams & Wilkins, 1996).
Krumholz HM, Seeman TE, Merril SS, et al. Lack of association between cholesterol and coronar heart disease mortality and morbidity and all cause mortality in persons older than 70 years. JAMA 1994;272(17):1335-40.
Kung AWC, Pang RWC, Janus ED. Elevated Serum Lipoprotein(a) in Subclinical Hypothyroidism. Clin Endocrinol 1995;43(4): 443-9.
Lovastatin Study Croups I through IV, "Lovastatin 5-Year Safety and Efficacy Study," Arch Intern Med 1993; 153: 1079-87.
Mader FH, Treatment of Hyperlipidemia with Garlic-Powder Tablets, Arzneim Forsch. 1990; 40:1111-6.
McKenney JM et al., A Comparison of the Efficacy and Toxic Effects of Sustained- vs Immediate-Release Niacin in Hypercholesterolemic Patients, JAMA 1994; 271: 672-7.
Merck patent United States Patent 4,933,165 June 12, 1990. (Cholesterol and Q10)
National Research Council, Diet and Health: Implications for Reducing Chronic Disease Risk, Washington, DC: National Academy Press,1989.
Neman TB and Hulley SB, Carcinogenicity of Lipid-Lowering Drugs, JAMA 1996;275: 55-60.
Reuter HD, Allium sativum and Allium ursinum, Part 2: Pharmacology and Medicinal Application, Phytomed 1995;2: 73-91.
Rotzch W et al., Postprandial Lipaemia under Treatment with Allium sativum Controlled Double Blind Study in Healthy Volunteers with Reduced HDL2 Cholesterol Levels, Arzneim Forsch 1992;42:1223-7.
Sainani GS et al., Effect of Dietary Garlic and Onion on Serum Lipid Profile in the Jain Community, Ind J Med Res 1979;69: 776-80.
Salonen JT, Nyyssönen K, Korpela H, et al. High Stored Iron Levels Are Associated With Excess Risk of Myocardial Infarction in Eastern Finnish Men. Circulation 1992; 86(3);803-11.
Scanu AM. Lipoprotein(a): A Genetic Risk Factor for Premature Coronary Heart Disease, JAMA 1992;267(24):3326-29.
Schaefer EJ et al., Lipoprotein(a) Levels and Risk of Coronary Heart Disease in Men: The Lipid Research Clinics Coronary Primary Prevention Trial, JAMA 1994; 271: 99-1003.
Silagy CA and Neil HA, A Meta Analysis of the Effect of Garlic on Blood Pressure, J Hypertens 1994; 12: 463-8.
Simon JA, "Vitamin C and Cardiovascular Disease: A Review," J Am Coll Nutr 1992;11:107 25.
Steiner M et al., "A Double-Blind Crossover Study in Moderately Hypercholesterolemic Men That Compared the Effect of Aged Garlic Extract and Placebo Administration on Blood Lipids," Am J Clin Nutr 64(1996): 866-70.
Sunderland GT, Belch JJ, Sturrock RD, et al., A Double-Blind Randomised Placebo Controlled Trial of Hexopal in Primary Raynaud's Disease, Clin Rheumatol 1988; 7(1):46-9.
Vega GL and Crundy SM, Lipoprotein Responses to Treatment with Lovastatin, Gemfibrozil, and Nicotinic Acid in Normolipidemic Patients with Hypoalphalipoproteinemia, Arch Intern Med 1994; 154: 73-82.
Warshafsky S, Kamer RS, Sivak SL, Effect of Garlic on Total Serum Cholesterol, Ann Intern Med 1993; 119:599-605.
Welsh AL and Ede M, Inositol Hexanicotinate for Improved Nicotinic Acid Therapy, Int Record Medn 1961; 174: 9-15.
Wilson PWF, High-Density Lipoprotein, Low-Density Lipoprotein, and Coronary Artery Disease," Am J Cardiol 1990;66: 7A-lOA.
